Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2026)

Adaptive Biotechnologies has disclosed Goodwill across 9 years of filings, most recently posting $119.0 million for Q1 2026.

• Goodwill for Q1 2026 came in at $119.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.0 million (changed 0.0% YoY), and the FY2025 annual result was $119.0 million, changed 0.0% from the prior year.
• Goodwill came in at $119.0 million for Q1 2026 at Adaptive Biotechnologies, roughly flat from $119.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $119.0 million in Q1 2022 to a low of $119.0 million in Q1 2022.
• The 5-year median for Goodwill is $119.0 million (2022), against an average of $119.0 million.
• Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Adaptive Biotechnologies' Goodwill stood at $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025, then changed by 0.0% to $119.0 million in 2026.
• The last three Goodwill figures came in at $119.0 million (Q1 2026), $119.0 million (Q4 2025), and $119.0 million (Q3 2025), per Business Quant data.